E Tech Group Secures New Investment from Graham Partners, Sets Stage for Continued Growth and Innovation

E Tech Group

E Tech Group, one of the nation’s leading automation system integrators, announced today a strategic investment with Graham Partners, a private equity firm focused on technology and advanced manufacturing.

The new investment follows significant growth with previous investors Falfurrias Capital Partners, including the execution and integration of two acquisitions in 2023 alone, bringing E Tech Group’s footprint to 25 locations throughout North America and a bench of 600 professionals focused on industrial automation and control solutions.

With this new round of investment from Graham Partners, E Tech Group is poised to continue its upward trajectory, doubling down on its commitment to innovation and providing the next level of automation services to clients. The infusion of capital will enable E Tech Group to further invest in cutting-edge tools, technologies, and talent, ensuring that it remains at the forefront of the industry.

Matt Wise, CEO of the E Tech Group

“The E Tech Group is on a mission to disrupt and reshape the world of industrial automation. This new investment will advance our ability to provide distinctive automation solutions, elevating efficiency and productivity while redefining how manufacturing is done in North America.”

Josh Wilson, Managing Principal at Graham Partners,

“We believe that Graham’s deep experience investing across the end markets served by E Tech positions us as an ideal partner to help the company execute on its next phase of growth.” Rob Newbold, Managing Principal at Graham Partners, added, “Graham has followed E Tech for a number of years, and our research showed it was a clear leader in automation integration. We are excited to be partnering with the E Tech team to continue executing on the exciting growth opportunities ahead of them, including additional targeted add-on acquisitions to expand the ability to serve customers across new end markets and geographies.”

Graham’s investment will help E Tech Group continue to redefine the role of system integrators in Industry 4.0. E Tech Group acts as a Main Automation Partner, guiding clients through their digital transformation journey, and allowing them to leverage a single partner to harden Operational Technology (OT) in facilities, standardize and optimize automation controls, and harvest data for Business Intelligence (BI) to enable smart next-generation manufacturing facilities.

“We are thrilled to partner with Graham Partners as we embark on the next phase of our journey,” said Wise. “Their expertise and resources will be instrumental in driving our continued growth and success. E Tech Group remains committed to its purpose, which is to free people to achieve the full potential of human creativity and innovation.”
E Tech Group secured Baird as its exclusive financial advisor for the investment, and terms were not disclosed.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”